Scarica l'app Stockscreener
4.06
2.01%
0.08
Dopo l'orario di chiusura:
4.08
0.02
+0.49%
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
Ironwood stock rises 27% on upbeat revenue guidance for 2026 - MSN
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating - MarketBeat
5 Small Drug Stocks to Buy as Industry Recovery Picks Up - Yahoo Finance
Ironwood hits 52-week high as AbbVie-partnered Linzess boosts 2026 outlook - MSN
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Craig Hallum - MarketBeat
There's No Escaping Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Muted Revenues Despite A 32% Share Price Rise - 富途牛牛
Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st
Why Ironwood Pharmaceuticals (IRWD) Is Up 37.8% After New 2026 Guidance And Ferring Settlement - Sahm
Citizens Upgrades Ironwood Pharmaceuticals (IRWD) - Nasdaq
Craig-Hallum Boosts Ironwood (IRWD) Rating with Optimistic Outlo - GuruFocus
Wells Fargo Raises Target Price for IRWD to $5.00 Maintaining Eq - GuruFocus
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 - Finviz
Wells Fargo & Company Forecasts Strong Price Appreciation for Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock - MarketBeat
Ironwood Pharmaceuticals Inc. (IRWD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
The Five-year Loss for Ironwood Pharmaceuticals (NASDAQ:IRWD) Shareholders Likely Driven by Its Shrinking Earnings - 富途牛牛
Ironwood Pharmaceuticals (IRWD) Upgraded to Market Outperform by Citizens | IRWD Stock News - GuruFocus
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Upgraded by Citizens Jmp - MarketBeat
Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED) - Benzinga
Ironwood Pharmaceuticals stock rises premarket after Citizens upgrade, Wells Fargo target lift - TechStock²
Ironwood Pharmaceuticals stock price target raised to $5 by Wells Fargo - Investing.com Canada
Citizens upgrades Ironwood Pharmaceuticals stock rating on LINZESS strength By Investing.com - Investing.com Canada
Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) Nasdaq Futures Pipeline Depth - Kalkine Media
Promising Pharmaceutical Stocks To ConsiderJanuary 2nd - MarketBeat
Ironwood Pharmaceuticals Surges on Linzess Sales Boost - StocksToTrade
Ironwood Pharmaceuticals’ Stock Surges as Higher Linzess Sales Drive Market Excitement - timothysykes.com
Ironwood Pharma leaps on 2025/2026 guidance - The Pharma Letter
Ironwood backs FY25 revenue view $290M-$310M, consensus $306.97M - Yahoo Finance
Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Ironwood Pharmaceuticals: Market Response to Legal Settlement - StocksToTrade
Ironwood Pharma (IRWD) Surges on Strong FY26 Guidance and Pipeli - GuruFocus
Stock soars at Boston biotech after it cuts price of IBS drug - The Business Journals
Ironwood Pharmaceuticals Stock (IRWD) Opinions on 2026 Financial Guidance - Quiver Quantitative
Ironwood Pharmaceuticals Stock Soars as Drug-Price Cut Boosts Prospects for 2026 - Barron's
Ironwood Pharmaceuticals stock soars on strong 2026 guidance By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals stock soars on strong 2026 guidance - Investing.com
Stock Traders Buy High Volume of Ironwood Pharmaceuticals Call Options (NASDAQ:IRWD) - MarketBeat
Ironwood Reaffirms FY2025 Revenue Outlook, Sees Growth In FY2026; Stock Surges - RTTNews
Ironwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month HighHere's Why - MarketBeat
Ironwood Pharmaceuticals, Baidu, Vertiv Holdings And Other Big Stocks Moving Higher On Friday - Benzinga
Why did Ironwood Pharmaceuticals stock skyrocket today? - MSN
Ironwood Pharma Stock Rallies On Strong 2026 OutlookIronwood Pharmaceuticals (NASDAQ:IRWD) - Benzinga
Why Did Ironwood Pharmaceuticals Stock Skyrocket Today? - Stocktwits
Ironwood’s Recent Move: A Catalyst for Change? - timothysykes.com
Why Is IRWD Stock Soaring Over 30% Premarket? 2026 Revenue Outlook Beats Estimates - Tokenist
Ironwood (IRWD) Focuses on Financial Growth and Drug Development - GuruFocus
Ironwood Pharmaceuticals, Inc. Maintains Earnings Guidance for Year 2025 and Provides Earnings Guidance for Year 2026 - MarketScreener
Ironwood Pharmaceuticals (IRWD) Projects Strong Revenue Growth f - GuruFocus
Ironwood Pharma Provides FY26 Outlook, Maintains Full Year Outlook - Nasdaq
Ironwood forecasts 2026 LINZESS sales to exceed $1.1 billion - Investing.com
Ironwood forecasts 2026 LINZESS sales to exceed $1.1 billion By Investing.com - Investing.com UK
0.37%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):